01228

1.5804.53%
JS

Joe Shen

Chief Operating Officer

Mr. Joe Shen is Chief Operating Officer of CANbridge Life Sciences Ltd. from October 2025 and was its Senior Vice President from 2024 to October 2025. Mr. Joe Shen was Senior Vice President of CANbridge Pharmaceuticals Inc. from 2024 until 2025 and serves as its Chief Operating Officer Since 2025. He serves as Senior Vice President at Canbridge Ltd. since 2024. He has considerable experience working in pharmaceutical manufacturing operations, quality, project management and plant operation management over a stellar career spanning more than 30 years. He held technical and managerial positions with increasing responsibilities at global pharmaceutical companies including Fresenius-Kabi Sino-Swed Pharmaceutical Company Ltd., Guangdong Otsuka and Suzhou Otsuka, Eisai(China) and Chinese domestic pharmaceutic companies including CTTQ, Nanjing Sanhome Pharmaceutical Company and Kintor Pharma. Over the last eight years, he held key executive level leadership roles with responsibilities in production, quality, project management and plant management & operations. He has developed substantial cross-cultural management experience. Mr. Shen has very rich professional knowledge and practical experience in the production, quality, equipment, validation and process of drugs, especially sterile products. He is familiar with major GMP regulations governed by major regulatory authorities including FDA, EMA and NMPA and has extensive hands-on experience with GMP inspection and audit of different countries and also has many successful cases during his career. He was one of the main drafters and revisers of China's 2010 version GMP, the main editor of the "Guidelines for the Implementation of Pharmaceutical GMP"-"Sterile Drugs" and assisted in revising the "Quality Management System", "Utilities and Facilities" and other guidelines, also being one expert reviewing members of "Pre-approval Inspection for Drug Registration" published by Peking university. Over one hundred of public lectures and training were conducted for CFDA, local provinces & cities and various industry forums. He graduated from Chinese Pharmaceutical University with a Pharmacy major and then earned his MBA master certificate in Southeast University.

Positions